People Briefs
This article was originally published in The Gray Sheet
Executive Summary
Sunshine Heart solidifies CEO appointment; Cook Endoscopy names new president; and more personnel updates from around the industry.
You may also be interested in...
Shuren In The Lion’s Den: Device Center Chief Defends LDT Plan At Clinical Lab Meeting, Fields Wide Array Of Questions
FDA device center Director Jeff Shuren explained and defended fine points of FDA’s proposed laboratory-developed test framework before some of his sharpest critics: members of the American Clinical Laboratory Association, who face an entirely new regulatory scheme once the LDT proposal is finalized.
People Briefs: Medtronic, Hologic, Cook Group, AxoGen, Rivanna
Medtronic exec VP and president, restorative therapies group; Hologic announces board changes; Cook Group names new president; AxoGen chief marketing officer resigns; Rivanna Medical appoints clinical advisor.
Research In Brief
Cook hemostasis spray: Early results of a safety study conducted in China show firm's endoscopic spray helps patients with peptic ulcer bleeds achieve hemostasis and stops re-bleeding, Cook reports April 7. Featuring a proprietary powder that can be sprayed directly onto a bleeding ulcer through the channel of an endoscope, the product may offer an alternative to devices like heating probes and clips in treating gastrointestinal (GI) bleeding, Barry Slowey, global business unit leader for Cook's endoscopy unit, said in an interview. Depending on the results of the 20-patient safety trial, which will be presented at the 2010 Digestive Disease Week conference in May, Cook will decide whether to move forward with a larger clinical study of the spray for GI bleeding by mid-year. About four to five million patients are treated annually for GI bleeds, representing a market of $160 million, Slowey noted